RT Journal Article
SR Electronic
T1 609 Phase 1/2a dose selection of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced solid malignancies
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A693
OP A693
DO 10.1136/jitc-2023-SITC2023.0609
VO 11
IS Suppl 1
A1 Glatt, Dylan M
A1 Kell, Sariah
A1 Schmidt, Maike
A1 Majeed, Sophia R
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A693.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.